EE200100681A - Puriinderivaadid - Google Patents

Puriinderivaadid

Info

Publication number: EE200100681A
Authority: EE; Estonia
Prior art keywords: purine derivatives; purine; derivatives
Prior art date: 1999-06-15

Application number

EEP200100681A

Other languages

English (en)

Inventor

John Mantell Simon

Marina Monaghan Sandra

Original Assignee

Pfizer Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-06-15

Filing date

2000-06-13

Publication date

2003-04-15

2000-06-13 Application filed by Pfizer Inc. filed Critical Pfizer Inc.

2003-04-15 Publication of EE200100681A publication Critical patent/EE200100681A/et

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
- C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/167—Purine radicals with ribosyl as the saccharide radical

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Immunology (AREA)
Dermatology (AREA)
Heart & Thoracic Surgery (AREA)
Diabetes (AREA)
Cardiology (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
Neurosurgery (AREA)
Endocrinology (AREA)
Vascular Medicine (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Hematology (AREA)
Obesity (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Otolaryngology (AREA)
Gynecology & Obstetrics (AREA)
Reproductive Health (AREA)
Communicable Diseases (AREA)

EEP200100681A 1999-06-15 2000-06-13 Puriinderivaadid EE200100681A (et)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9913932.1A GB9913932D0 (en)	1999-06-15	1999-06-15	Purine derivatives
PCT/IB2000/000789 WO2000077018A2 (en)	1999-06-15	2000-06-13	Purine derivatives

Publications (1)

Publication Number	Publication Date
EE200100681A true EE200100681A (et)	2003-04-15

Family

ID=10855403

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EEP200100681A EE200100681A (et)	1999-06-15	2000-06-13	Puriinderivaadid

Country Status (38)

Country	Link
US (2)	US6900309B1 (et)
EP (1)	EP1185542A2 (et)
JP (1)	JP2003502339A (et)
KR (1)	KR20020010707A (et)
CN (1)	CN1179970C (et)
AP (1)	AP2001002361A0 (et)
AR (1)	AR024345A1 (et)
AU (1)	AU764106B2 (et)
BG (1)	BG106289A (et)
BR (1)	BR0011705A (et)
CA (1)	CA2379786C (et)
CZ (1)	CZ20014397A3 (et)
DZ (1)	DZ3168A1 (et)
EA (1)	EA004861B1 (et)
EC (1)	ECSP003531A (et)
EE (1)	EE200100681A (et)
GB (1)	GB9913932D0 (et)
GT (1)	GT200000096A (et)
HN (1)	HN2000000097A (et)
HR (1)	HRP20010927A2 (et)
HU (1)	HUP0203419A3 (et)
IL (1)	IL147098A0 (et)
IS (1)	IS6196A (et)
MA (1)	MA26799A1 (et)
MX (1)	MXPA01013094A (et)
NO (1)	NO20016109L (et)
NZ (1)	NZ516094A (et)
OA (1)	OA11968A (et)
PA (1)	PA8497001A1 (et)
PE (1)	PE20010430A1 (et)
PL (1)	PL354367A1 (et)
SK (1)	SK18192001A3 (et)
SV (1)	SV2001000100A (et)
TN (1)	TNSN00133A1 (et)
TR (1)	TR200103607T2 (et)
UY (1)	UY26204A1 (et)
WO (1)	WO2000077018A2 (et)
ZA (1)	ZA200110208B (et)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU5879299A (en) *	1998-10-16	2000-05-08	Monaghan, Sandra Marina	Adenine derivatives
GB9913932D0 (en) *	1999-06-15	1999-08-18	Pfizer Ltd	Purine derivatives
GB9924361D0 (en)	1999-10-14	1999-12-15	Pfizer Ltd	Purine derivatives
GB0003960D0 (en)	2000-02-18	2000-04-12	Pfizer Ltd	Purine derivatives
US6753322B2 (en) *	2000-06-06	2004-06-22	Pfizer Inc	2-aminocarbonyl-9H-purine derivatives
TWI227240B (en) *	2000-06-06	2005-02-01	Pfizer	2-aminocarbonyl-9H-purine derivatives
GB0015727D0 (en) *	2000-06-27	2000-08-16	Pfizer Ltd	Purine derivatives
US6921753B2 (en)	2000-06-27	2005-07-26	Pfizer Inc	Purine derivatives
GB0022695D0 (en)	2000-09-15	2000-11-01	Pfizer Ltd	Purine Derivatives
GB0104555D0 (en) *	2001-02-23	2001-04-11	Glaxo Group Ltd	New Therapeutic method
WO2002072067A2 (en) *	2001-03-12	2002-09-19	Glaxo Group Limited	Pharmaceutical aerosol formulation
GB0129273D0 (en)	2001-12-06	2002-01-23	Pfizer Ltd	Crystalline drug form
GB0129397D0 (en) *	2001-12-07	2002-01-30	Pfizer Ltd	Pharmaceutical combination
GB0228723D0 (en)	2002-12-09	2003-01-15	Cambridge Biotechnology Ltd	Treatment of pain
AR044519A1 (es)	2003-05-02	2005-09-14	Novartis Ag	Derivados de piridin-tiazol amina y de pirimidin-tiazol amina
WO2005019238A1 (ja) *	2003-08-22	2005-03-03	Meiji Seika Kaisha, Ltd.	新規アザライド及びアザラクタム誘導体とその製造法
JP2005132767A (ja) *	2003-10-30	2005-05-26	Sumitomo Chemical Co Ltd	プリン化合物の製造方法
GB0401334D0 (en)	2004-01-21	2004-02-25	Novartis Ag	Organic compounds
TWI346109B (en) *	2004-04-30	2011-08-01	Otsuka Pharma Co Ltd	4-amino-5-cyanopyrimidine derivatives
GB0411056D0 (en)	2004-05-18	2004-06-23	Novartis Ag	Organic compounds
GB0424284D0 (en)	2004-11-02	2004-12-01	Novartis Ag	Organic compounds
GB0426164D0 (en)	2004-11-29	2004-12-29	Novartis Ag	Organic compounds
GB0500785D0 (en) *	2005-01-14	2005-02-23	Novartis Ag	Organic compounds
GB0510390D0 (en)	2005-05-20	2005-06-29	Novartis Ag	Organic compounds
MY144906A (en)	2005-10-21	2011-11-30	Novartis Ag	Human antibodies against il13 and therapeutic uses
GB0601951D0 (en)	2006-01-31	2006-03-15	Novartis Ag	Organic compounds
KR101494125B1 (ko) *	2006-02-03	2015-02-16	길리애드 사이언시즈, 인코포레이티드	Ａ2ａ-아데노신 수용체 효능제 및 이의 다형체의 제조 방법
MX2009003185A (es)	2006-09-29	2009-04-03	Novartis Ag	Pirazolopirimidinas como inhibidores de lipido cinasa pi3k.
AU2007315234A1 (en)	2006-10-30	2008-05-08	Novartis Ag	Heterocyclic compounds as antiinflammatory agents
CN101910153B (zh)	2008-01-11	2014-01-22	诺华股份有限公司	作为激酶抑制剂的嘧啶类
PT2391366E (pt)	2009-01-29	2013-02-05	Novartis Ag	Benzimidazoles substituídos para o tratamento de astrocitomas
US8389526B2 (en)	2009-08-07	2013-03-05	Novartis Ag	3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives
BR112012003262A8 (pt)	2009-08-12	2016-05-17	Novartis Ag	compostos de hidrazona heterocíclica e seus usos para tratar câncer e inflamação
PE20121148A1 (es)	2009-08-17	2012-09-07	Intellikine Llc	Compuestos heterociclicos y usos de los mismos
BR112012008061A2 (pt)	2009-08-20	2016-03-01	Novartis Ag	compostos de oxima heterocíclica
WO2012034095A1 (en)	2010-09-09	2012-03-15	Irm Llc	Compounds and compositions as trk inhibitors
UY33597A (es)	2010-09-09	2012-04-30	Irm Llc	Compuestos y composiciones como inhibidores de la trk
EP2673277A1 (en)	2011-02-10	2013-12-18	Novartis AG	[1, 2, 4]triazolo [4, 3 -b]pyridazine compounds as inhibitors of the c-met tyrosine kinase
JP5808826B2 (ja)	2011-02-23	2015-11-10	インテリカイン，エルエルシー	複素環化合物およびその使用
BR112013021638A2 (pt)	2011-02-25	2016-08-02	Irm Llc	"compostos inibidores de trk, seu uso e composições que os compreendem"
EP2755976B1 (en)	2011-09-15	2018-07-18	Novartis AG	6-substituted 3-(quinolin-6-ylthio)-[1,2,4]triazolo[4,3-a]pyridines as c-met tyrosine kinase inhibitors
US20130209543A1 (en)	2011-11-23	2013-08-15	Intellikine Llc	Enhanced treatment regimens using mtor inhibitors
JP2015512425A (ja)	2012-04-03	2015-04-27	ノバルティスアーゲー	チロシンキナーゼ阻害剤との組合せ製品及びそれらの使用
WO2014151147A1 (en)	2013-03-15	2014-09-25	Intellikine, Llc	Combination of kinase inhibitors and uses thereof
WO2015084804A1 (en)	2013-12-03	2015-06-11	Novartis Ag	Combination of mdm2 inhibitor and braf inhibitor and their use
WO2016011658A1 (en)	2014-07-25	2016-01-28	Novartis Ag	Combination therapy
AU2015294889B2 (en)	2014-07-31	2018-03-15	Novartis Ag	Combination therapy
US12324807B2 (en)	2018-06-01	2025-06-10	Cornell University	Combination therapy for PI3K-associated disease or disorder
TW202140550A (zh)	2020-01-29	2021-11-01	瑞士商諾華公司	使用抗ｔｓｌｐ抗體治療炎性或阻塞性氣道疾病之方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5536419A (en)	1978-09-08	1980-03-14	Yamasa Shoyu Co Ltd	2-substituted adenosine derivative and its preparation
JPS55153789A (en) *	1979-04-11	1980-11-29	Sankyo Co Ltd	Penem-3-carboxylic acid derivative and its preparation
JPS55153798A (en) *	1979-05-18	1980-11-29	Kikkoman Corp	Novel 2-substituted-adenosine 3',5'-cyclic phosphate and its preparation
JPH0313934A (ja) *	1989-06-12	1991-01-22	Konica Corp	ハロゲン化銀写真感光材料
US5376645A (en)	1990-01-23	1994-12-27	University Of Kansas	Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
KR0166088B1 (ko)	1990-01-23	1999-01-15	.	수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
EP0601322A3 (en)	1992-10-27	1994-10-12	Nippon Zoki Pharmaceutical Co	Adenosine deaminase inhibitor.
DK155292D0 (da)	1992-12-23	1992-12-23	Novo Nordisk As	Kemiske forbindelser, deres fremstilling og anvendelse
JP3362291B2 (ja) *	1993-10-06	2003-01-07	コニカ株式会社	ハロゲン化銀写真感光材料及び画像形成方法
RO119116B1 (ro) *	1995-04-14	2004-04-30	Glaxo Wellcome Inc.	Inhalator pentru dozarea salmeterolului
GB9711643D0 (en)	1997-06-05	1997-07-30	Janssen Pharmaceutica Nv	Glass thermoplastic systems
ZA9810490B (en)	1997-12-03	1999-05-20	Dainippon Pharmaceutical Co	2-Aryl-8-oxodihydropurine derivative process for the preparation thereof pharmaceutical composition containing the same and intermediate therefor
US6232297B1 (en)	1999-02-01	2001-05-15	University Of Virginia Patent Foundation	Methods and compositions for treating inflammatory response
RU2258071C2 (ru)	1999-05-24	2005-08-10	Юниверсити Оф Вирджиния Пэйтент Фаундейшн	Производные 2-алкиниладенозина для борьбы с воспалительной реакцией
GB9913932D0 (en) *	1999-06-15	1999-08-18	Pfizer Ltd	Purine derivatives
GB0003960D0 (en) *	2000-02-18	2000-04-12	Pfizer Ltd	Purine derivatives

1999
- 1999-06-15 GB GBGB9913932.1A patent/GB9913932D0/en not_active Ceased
2000
- 2000-06-08 US US09/590,585 patent/US6900309B1/en not_active Expired - Fee Related
- 2000-06-13 DZ DZ003168A patent/DZ3168A1/xx active
- 2000-06-13 EA EA200101203A patent/EA004861B1/ru not_active IP Right Cessation
- 2000-06-13 HU HU0203419A patent/HUP0203419A3/hu unknown
- 2000-06-13 AP APAP/P/2001/002361A patent/AP2001002361A0/en unknown
- 2000-06-13 EE EEP200100681A patent/EE200100681A/et unknown
- 2000-06-13 JP JP2001503875A patent/JP2003502339A/ja not_active Ceased
- 2000-06-13 AU AU49443/00A patent/AU764106B2/en not_active Ceased
- 2000-06-13 TR TR2001/03607T patent/TR200103607T2/xx unknown
- 2000-06-13 KR KR1020017016127A patent/KR20020010707A/ko not_active Ceased
- 2000-06-13 BR BR0011705-6A patent/BR0011705A/pt not_active IP Right Cessation
- 2000-06-13 NZ NZ516094A patent/NZ516094A/en unknown
- 2000-06-13 OA OA1200100332A patent/OA11968A/en unknown
- 2000-06-13 CA CA002379786A patent/CA2379786C/en not_active Expired - Fee Related
- 2000-06-13 HR HR20010927A patent/HRP20010927A2/hr not_active Application Discontinuation
- 2000-06-13 AR ARP000102905A patent/AR024345A1/es unknown
- 2000-06-13 HN HN2000000097A patent/HN2000000097A/es unknown
- 2000-06-13 IL IL14709800A patent/IL147098A0/xx unknown
- 2000-06-13 EP EP00931495A patent/EP1185542A2/en not_active Withdrawn
- 2000-06-13 MX MXPA01013094A patent/MXPA01013094A/es active IP Right Grant
- 2000-06-13 CN CNB008130647A patent/CN1179970C/zh not_active Expired - Fee Related
- 2000-06-13 PE PE2000000582A patent/PE20010430A1/es not_active Application Discontinuation
- 2000-06-13 CZ CZ20014397A patent/CZ20014397A3/cs unknown
- 2000-06-13 SK SK1819-2001A patent/SK18192001A3/sk unknown
- 2000-06-13 UY UY26204A patent/UY26204A1/es not_active Application Discontinuation
- 2000-06-13 PL PL00354367A patent/PL354367A1/xx not_active Application Discontinuation
- 2000-06-13 WO PCT/IB2000/000789 patent/WO2000077018A2/en not_active Ceased
- 2000-06-14 EC EC2000003531A patent/ECSP003531A/es unknown
- 2000-06-14 SV SV2000000100A patent/SV2001000100A/es unknown
- 2000-06-14 TN TNTNSN00133A patent/TNSN00133A1/fr unknown
- 2000-06-14 GT GT200000096A patent/GT200000096A/es unknown
- 2000-06-14 PA PA20008497001A patent/PA8497001A1/es unknown
2001
- 2001-12-11 IS IS6196A patent/IS6196A/is unknown
- 2001-12-12 MA MA26440A patent/MA26799A1/fr unknown
- 2001-12-12 ZA ZA200110208A patent/ZA200110208B/xx unknown
- 2001-12-14 NO NO20016109A patent/NO20016109L/no not_active Application Discontinuation
2002
- 2002-01-08 BG BG06289A patent/BG106289A/xx unknown
2005
- 2005-01-24 US US11/042,582 patent/US20050124574A1/en not_active Abandoned

Also Published As

Publication number	Publication date
WO2000077018A3 (en)	2001-12-06
SK18192001A3 (sk)	2003-04-01
PE20010430A1 (es)	2001-04-14
EP1185542A2 (en)	2002-03-13
CN1179970C (zh)	2004-12-15
ZA200110208B (en)	2002-12-12
HRP20010927A2 (en)	2003-04-30
IL147098A0 (en)	2002-08-14
EA004861B1 (ru)	2004-08-26
MXPA01013094A (es)	2002-06-04
HN2000000097A (es)	2001-03-14
CA2379786C (en)	2006-11-28
GB9913932D0 (en)	1999-08-18
KR20020010707A (ko)	2002-02-04
AU4944300A (en)	2001-01-02
HUP0203419A3 (en)	2005-02-28
DZ3168A1 (fr)	2000-12-21
US20050124574A1 (en)	2005-06-09
WO2000077018A2 (en)	2000-12-21
TR200103607T2 (tr)	2002-10-21
HK1047111A1 (en)	2003-02-07
CZ20014397A3 (cs)	2003-04-16
PL354367A1 (en)	2004-01-12
CN1374966A (zh)	2002-10-16
JP2003502339A (ja)	2003-01-21
NO20016109D0 (no)	2001-12-14
SV2001000100A (es)	2001-11-08
IS6196A (is)	2001-12-11
UY26204A1 (es)	2001-01-31
MA26799A1 (fr)	2004-12-20
ECSP003531A (es)	2002-01-25
BR0011705A (pt)	2002-03-26
OA11968A (en)	2006-04-17
EA200101203A1 (ru)	2002-06-27
GT200000096A (es)	2001-12-06
US6900309B1 (en)	2005-05-31
TNSN00133A1 (fr)	2002-05-30
NO20016109L (no)	2002-02-15
AP2001002361A0 (en)	2001-12-31
AR024345A1 (es)	2002-10-02
CA2379786A1 (en)	2000-12-21
PA8497001A1 (es)	2001-12-14
HUP0203419A2 (hu)	2003-02-28
NZ516094A (en)	2004-07-30
BG106289A (en)	2002-09-30
AU764106B2 (en)	2003-08-07

Publication	Publication Date	Title
DE60026861D1 (de)	2006-05-11	Purin-derivate
ATE238336T1 (de)	2003-05-15	Purin-derivate
EE200100681A (et)	2003-04-15	Puriinderivaadid
NO20010743D0 (no)	2001-02-14	Antivirale indoloksoacetyl-piperazin-derivater
DE60119492D1 (de)	2006-06-14	Purinderivate
DK1296996T3 (da)	2004-08-16	Purinderivater
NO20000885L (no)	2000-08-25	4-Fenyl-pyridin-derivater
DE60009747D1 (de)	2004-05-13	Admantan-derivate
DE50010060D1 (de)	2005-05-19	Thiazolylamid-derivate
DK1187814T3 (da)	2004-12-20	5-phenyl-pyrimidinderivater
ATE257148T1 (de)	2004-01-15	Propargyletherderivate
ATE273272T1 (de)	2004-08-15	Mevinolinderivate
ATE374747T1 (de)	2007-10-15	Monofluoralkylderivate
DE60006703D1 (de)	2003-12-24	4-hydroxybiphenylhydrazid-derivate
ATE293592T1 (de)	2005-05-15	Resorcinderivate
DK1178984T3 (da)	2003-06-10	1-trifluormethyl-4-hydroxy-7-piperidinylaminomethylchroman-derivater
ATE269328T1 (de)	2004-07-15	1-cycloalkylpyrazolyl-benzoyl-derivate
DK1090019T3 (da)	2005-02-07	Adenosinderivater